Apellis UK Limited
Registered name: APELLIS UK LIMITED
Part of Apellis Pharmaceuticals, Inc. groupApellis UK Limited made £4.7m revenue and £127k profit in the year to 31 Dec 2025.
Apellis UK Limited’s revenue fell 26% to £4.7m in the year to 31 Dec 2025, with £127k profit and 11 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in London; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 6 yrs · since 2020
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £6.6m | £6.4m | £4.7m |
| Gross profit | £6.6m | £6.4m | £4.7m |
| Operating profit | £218k | £239k | £163k |
| Profit before tax | £218k | £241k | £167k |
| Profit after tax | £163k | £185k | £127k |
| Profit (best available) | £163k | £185k | £127k |
| Staff costs | £3.8m | £4.7m | £4.1m |
| Employees (average) | 10 | 11 | 11 |
| Ratios | |||
| Profit margin | 2.5% | 2.9% | 2.7% |
| Gross margin | 100% | 100% | 100% |
| Revenue per employee | £658k | £583k | £431k |
| Profit per employee | £16.3k | £16.8k | £11.5k |
| Cash conversion | 284.9% | 58.4% | −9.9% |
| Growth (year on year) | |||
| Revenue growth | — | ▼2.5% | ▼26.1% |
| Profit growth | — | ▲13.4% | ▼31.5% |
| Headcount growth | — | ▲10% | 0% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | −£318k | £637k | £880k |
| Net assets | — | — | — |
| Current assets | £2.3m | £1.6m | £1.4m |
| Debtors | £1.9m | £1m | £562k |
| Cash from operations | £620k | £139k | −£16.1k |
| Source | Reports and Financial Statements · bulk data Nov 2025 | Reports and Financial Statements · bulk data Nov 2025 | Reports and Financial Statements · bulk data Sep 2026 |
How the business works
- Profit margin
- 2.7%
- Profit ÷ revenue.
- Gross margin
- 100%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £431k
- Revenue ÷ average employees.
- Profit per employee
- £11.5k
- Profit ÷ average employees.
- Cash conversion
- −9.9%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 11.8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- ▲38%
- Now £880k
- Headcount
- 0%
- Now 11
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Apellis Pharmaceuticals, Inc. (registered outside the UK register)ultimate parent75–100%
- Apellis UK Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Ananta Medicare LtdFulham London · Wholesale of pharmaceutical goods
- Revenue
- £4.7m
- Profit
- £90.9k
- Staff
- 3
- Arena Pharmaceuticals LimitedBuckingham · Wholesale of pharmaceutical goods
- Revenue
- £4.5m
- Profit
- £394k
- Staff
- 3
- Abacus Medicine Pharma Services LtdFarnborough · Wholesale of pharmaceutical goods
- Revenue
- £6.3m
- Profit
- £348k
- Staff
- 21
- Itf Pharma LtdLondon · Wholesale of pharmaceutical goods
- Revenue
- £3.6m
- Profit
- £320k
- Staff
- 9
- Lucis Pharma LtdLeeds · Wholesale of pharmaceutical goods
- Revenue
- £3.5m
- Profit
- £2m
- Staff
- —
- Recordati Rare Diseases UK LimitedMaidenhead · Wholesale of pharmaceutical goods
- Revenue
- £6.4m
- Profit
- £123k
- Staff
- 9
Sources
Latest figures from Reports and Financial Statements for the year to 31 Dec 2025 (profit £127k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.